Skip to main content

Telos Corporation Announces First Quarter 2026 Earnings

ASHBURN, Va., May 11, 2026 (GLOBE NEWSWIRE) — Telos Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, has posted its 2026 first quarter financial results on its investor relations website at https://investors.telos.com. Telos will host a live webcast to discuss its first quarter 2026 financial results today, May 11, 2026, at 9:30 a.m. ET. To access the webcast, visit https://edge.media-server.com/mmc/p/so4sxhaa. Related presentation materials will be available in the Investors section of the Company’s website. In addition, an archived webcast will be posted on the website approximately two hours after the live event concludes. About Telos CorporationTelos Corporation (NASDAQ: TLS) empowers and protects the world’s most security-conscious...

Continue reading

Adial Pharmaceuticals Reports 2026 First Quarter Financial Results and Provides Business Update

GLEN ALLEN, Va., May 11, 2026 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today provided a business update and reported its financial results for the 2026 first quarter ended March 31, 2026. “We are very encouraged by the continued progress we have made in early 2026 to advance AD04 toward late-stage development, particularly in light of several important regulatory and strategic developments that we believe meaningfully strengthen our path forward,” said Cary Claiborne, Chief Executive Officer of Adial. “Most notably, recent Food and Drug Administration (FDA) policy discussions indicating that, in certain scientifically justified cases, approval...

Continue reading

eXp World Holdings Reports Q1 2026 Results

eXp World Holdings Reports Q1 2026 ResultseXp World Holdings Reports Q1 2026 ResultsBELLINGHAM, Wash., May 11, 2026 (GLOBE NEWSWIRE) — eXp World Holdings, Inc. (Nasdaq: AGNT) (the “Company,” “eXp” or “we”), the holding company for eXp Realty®, NextHome, Inc., FrameVR.io and SUCCESS® Enterprises, today announced financial results for the first quarter 2026 ended March 31, 2026. “Our first quarter results exceeded our revenue expectations as agent productivity continues to increase,” said Leo Pareja, CEO of eXp Realty. “We have always been a company built by agents, built for agents, and this quarter we’ve taken a meaningful step in broadening that mission. The addition of NextHome creates maximum optionality across our platform. This multi-model approach serves the full spectrum of real estate entrepreneurs on a single,...

Continue reading

Kaspi.kz 1Q 2026 Financial Results

ALMATY, Kazakhstan, May 11, 2026 (GLOBE NEWSWIRE) — Joint Stock Company Kaspi.kz (“Kaspi.kz”, “we”) (Nasdaq:KSPI) today published its unaudited consolidated IFRS financial results for the quarter ended 31 March 2026 (“1Q 2026”). Letter from Mikheil Lomtadze, Co-Founder and CEO of Kaspi.kz: We’ve started the year with strong e-Commerce growth, higher purchase frequency and improving monetization. e-Commerce GMV grew 41% year-over-year on a constant-currency and pro-forma basis and orders grew 43% on pro-forma basis. Consumers are buying more frequently — purchases per consumer increased 44% to 15 purchases per quarter. At the same time, Kaspi.kz remained highly profitable, with adjusted EBITDA growing 9%. Our Board recommended a dividend of KZT 850 per ADS, representing a 64% payout ratio, subject to shareholder approval. This reflects...

Continue reading

EchoStar Announces Financial Results for the Three Months Ended March 31, 2026

ENGLEWOOD, Colo., May 11, 2026 (GLOBE NEWSWIRE) — EchoStar Corporation (NASDAQ: SATS) reported first quarter 2026 total revenue of $3.67 billion, compared to $3.87 billion in 2025. Net loss attributable to EchoStar in the first quarter of 2026 totaled $146.89 million, compared to $202.67 million in the year-ago quarter. Diluted loss per share was $0.51 in the first quarter of 2026, compared to $0.71 in 2025. Pay-TVNet pay-TV subscribers decreased approximately 366,000 in the first quarter of 2026, compared to a decrease of approximately 381,000 in the year-ago quarter. The company closed the quarter with 6.63 million pay-TV subscribers, including 4.84 million DISH TV subscribers and 1.79 million Sling TV subscribers.Retail WirelessRetail wireless subscribers increased by approximately 16,000 in the first quarter of 2026,...

Continue reading

Cineplex Reports First Quarter 2026 Results

TORONTO, May 11, 2026 (GLOBE NEWSWIRE) — Today, Cineplex Inc. (“Cineplex” or the “Company”) released its financial results for the three months ended March 31, 2026. Unless otherwise specified, all amounts contained in this news release are in Canadian dollars. Q1 2026 Highlights:Recorded $291.0 million in total revenues, the highest first quarter revenue since 2019 Achieved box office revenues of $127.4 million, an increase of 25% over the prior year Set first quarter records for Box Office Per Patron (“BPP”) at $12.94 and Concession Per Patron (“CPP”) at $9.54 International film product represented 13.0% of total box office revenues and delivered the highest first quarter box office revenues from international content in the Company’s history Location-Based Entertainment delivered store-level EBITDAaL Margin of 25% in line with...

Continue reading

Liquidia Corporation Reports First Quarter 2026 Financial Results

YUTREPIA® (treprostinil) inhalation powder net product sales of approximately $130 million in the first quarter of 2026 More than 4,500 unique patient prescriptions and approximately 3,750 patients treated between launch in June 2025 and April 30, 2026 Recorded third consecutive quarter of profitability, with net income of approximately $53 million, adjusted EBITDA of $71 million and an increase in cash and cash equivalents by $32 million compared to the fourth quarter of 2025 Actively screening PH-ILD patients in Phase 4 Tyvaso® and Tyvaso DPI® transition study and pivotal Phase 3 Re-Spire study of L606MORRISVILLE, N.C., May 11, 2026 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular...

Continue reading

OLAPLEX Reports First Quarter 2026 Results

NEW YORK, NY, May 11, 2026 (GLOBE NEWSWIRE) — Olaplex Holdings, Inc. (NASDAQ: OLPX) (“OLAPLEX” or the “Company”) today announced financial results for the first quarter ended March 31, 2026. Amanda Baldwin, OLAPLEX’s Chief Executive Officer, commented: “We delivered a solid start to the year with positive quarterly sell-through led by the successful launch of No. 3 PLUS. Through the disciplined operational execution of our transformation priorities, our higher sales translated to a strong quarter. I want to again thank the entire Olaplex team for their continued dedication and commitment to our transformation.” For the first quarter of 2026 compared to the first quarter of 2025:Net sales increased 2.5% to $99.4 million;By channel:Specialty Retail decreased 13.3% to $33.4 million; Professional...

Continue reading

Certara Reports First Quarter 2026 Financial Results

Updates 2026 Guidance to reflect completed divestiture of Regulatory Writing and Medical Writing Business RADNOR, Pa., May 11, 2026 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its first quarter 2026 financial results. First Quarter Highlights:Revenue was $106.9 million, compared to $106.0 million in the first quarter of 2025, representing growth of 1%.Software revenue was $49.7 million, compared to $46.4 million in the first quarter of 2025, representing growth of 7%. Services revenue was $57.2 million, compared to $59.6 million in the first quarter of 2025, representing a decrease of 4%.Net loss was $8.8 million, compared to a net income of $4.7 million in the first quarter of 2025, representing a decrease of 285%. Adjusted EBITDA was $31.7 million,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.